Abstract
Glucose-induced insulinomimetic peptide (GIP) is a gut hormone produced by enteroendocrine K-cells in the intestinal mucosa in response to fat, glucose, and also protein. GIP releases insulin from the β cells of the pancreatic islets of Langerhans and therefore is an incretin hormone. GIP acts on a G-protein–coupled receptor that is widely distributed in the body including adipose tissue, stomach, brain, and others. Deletion of the GIP receptor (GIPR) renders mice resistant to weight gain induced by a high fat diet.
We observed that weight gain induced by ovarectomy in female mice is prevented by GIPR deletion that is linked to reduced food intake and reduced hypothalamic expression of orectic neurotransmitters. Moreover, old male GIPR−/− mice placed on a high glycemic index diet maintained a high insulin sensitivity and were much more active than controls, which was not seen in young animals. Thus, GIP elicits central effects in response to nutrients that protect against obesity and insulin resistance. We then investigated the acute responses of humans to treatment with GIP over 4h in a dose mimicking postprandial plasma levels of about 100pmol/L. At basal glucose, GIP does not elicit insulin release. Fat biopsies taken before and after 4h of GIP treatment were analyzed for transcriptomic responses using Agilent whole human genome assays. There was a highly significant upregulation of an inflammatory expression pattern in a pathway analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Enc FY, Imeryuz N, Akin L, Turoglu T, Dede F, Haklar G, Tekesin N, Bekiroglu N, Yegen BC, Rehfeld JF, Holst JJ, Ulusoy NB (2001) Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol Gastrointest Liver Physiol 281:G752–763
Ferrannini E, Mingrone G (2009) Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 32:514–520
Flatt PR (2008) Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabet Med 25:759–764
Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ (2007) Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest 117:143–152
Irwin N, Flatt PR (2009) Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 52:1724–1731
Isken F, Pfeiffer AFH, Nogueiras R, Osterhoff MA, Ristow M, Tschöp M, Weickert MO (2008) Deficiency for the glucose-dependent insulinotropic polypeptide (GIP) receptor prevents ovarectomy-induced body mass gain. Am J Physiol 295:E350–355
Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO (2009) Impairment of fat oxidation under high vs low glycemic index diet occurs prior to the development of an obese phenotype. Am J Physiol Endocrinol Metab
Isken F, Weickert MO, Tschop MH, Nogueiras R, Mohlig M, Abdelrahman A, Klaus S, Thorens B, Pfeiffer AF (2009b) Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia 52:2159–2168
Mingrone G, Castagneto M (2009) Bariatric surgery: unstressing or boosting the beta-cell? Diabetes Obes Metab 11(Suppl 4):130–142
Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738–742
Rudovich N, Kaiser S, Engeli S, Osterhoff M, Gogebakan O, Bluher M, Pfeiffer AF (2007) GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept 142:138–145
Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Pfeiffer, A.F.H., Rudovich, N., Weickert, M.O., Isken, F. (2011). Role of the Gut Peptide Glucose-Induced Insulinomimetic Peptide in Energy Balance. In: Meyerhof, W., Beisiegel, U., Joost, HG. (eds) Sensory and Metabolic Control of Energy Balance. Results and Problems in Cell Differentiation, vol 52. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14426-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-14426-4_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-14425-7
Online ISBN: 978-3-642-14426-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)